Sales 2024 * | 400K 547K | Sales 2025 * | 250K 342K | Capitalization | 37.64M 51.46M |
---|---|---|---|---|---|
Net income 2024 * | -32M -43.75M | Net income 2025 * | -40M -54.68M | EV / Sales 2024 * | 94.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 151 x |
P/E ratio 2024 * |
-3.3
x | P/E ratio 2025 * |
-3.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.62% |
Latest transcript on Foamix Pharmaceuticals Ltd.
Managers | Title | Age | Since |
---|---|---|---|
David Domzalski
CEO | Chief Executive Officer | 58 | 20-02-29 |
Tyler Zeronda
DFI | Director of Finance/CFO | 38 | - |
Iain Stuart
CTO | Chief Tech/Sci/R&D Officer | 51 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pat LePore
BRD | Director/Board Member | 69 | 20-09-09 |
Steven Basta
BRD | Director/Board Member | 59 | 14-12-31 |
Anthony Bruno
BRD | Director/Board Member | 68 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+30.02% | 684B | |
+30.34% | 568B | |
-3.95% | 361B | |
+18.17% | 329B | |
+4.09% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.74% | 166B |